Advertisement

Topics

Swiss Vaccine Research Institute Company Profile

12:01 EDT 25th June 2018 | BioPortfolio

The SVRI is a partnership of five research institutes in Switzerland. The SVRI was created in 2007 in Lausanne and is supported by the Swiss Secretariat of Education and Research. Its primary objective is to develop effective preventive vaccine strategies and therapeutic vaccine interventions for infectious diseases and for cancer. SVRI plays an instrumental role in linking basic research to translational research. SVRI’s research program targets primarily HIV/AIDS, malaria, tuberculosis, as well as the emerging influenza pandemic threat. SVRI benefits also from ongoing efforts in the area of cancer vaccine research. The SVRI hosting house is the Lausanne University Hospital (Lausanne, Switzerland).


News Articles [2927 Associated News Articles listed on BioPortfolio]

Horizon and The Pirbright Institute to collaborate on vaccine research programme

A partnership has been formed between Horizon Discovery Group and The Pirbright Institute to cover collaborative work on a research programme aimed at deploying cell engineering to increase vaccine yi...

Heroin vaccine blocks lethal overdose

(Scripps Research Institute) Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block ...

NIAID unveils strategic plan for developing a universal influenza vaccine

(NIH/National Institute of Allergy and Infectious Diseases) Developing a universal influenza vaccine -- a vaccine that can provide durable protection for all age groups against multiple strains, inclu...

Wistar receives Clinical Research Forum Award for DNA-based Zika research

(The Wistar Institute) The Wistar Institute and partners at the Perelman School of Medicine at the University of Pennsylvania, Inovio Pharmaceuticals, and GeneOne Life Science were recognized among th...

Merck to partner with Jenner Institute to speed up vaccine availability

Science and technology company, Merck, has partnered with Oxford University’s Jenner Institute to develop cost-effective vaccine manufacturing processes, aimed at speeding up vaccine availability.

New understanding of parasite biology might help stop malaria transmission

(Swiss Tropical and Public Health Institute) Researchers at the Swiss Tropical and Public Health Institute made an important step toward deeper understanding of how malaria blood stage parasites turn ...

Roche names Pao as Swiss R&D head after Reed exits

ZURICH (Reuters) - Swiss drugmaker Roche said it will put a cancer specialist at the helm of its Swiss-based research efforts in April, after the scientist who led the unit for five years resigned for...

Wistar Institute Awarded Grant to Create a Malaria Vaccine Through Synthetic DNA-Based Technology

The Wistar Institute announces it has been awarded a $1,494,972 grant by the Bill & Melinda Gates Foundation to advance a DNA-based vaccine candidate for protection against malarial infection util...

PubMed Articles [2216 Associated PubMed Articles listed on BioPortfolio]

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

A priority for the National Institute of Allergy and Infectious Diseases (NIAID) is development of an influenza vaccine providing durable protection against multiple influenza strains, including those...

The vaccine hesitancy scale: Psychometric properties and validation.

The SAGE Working Group on Vaccine Hesitancy developed a vaccine hesitancy measure, the Vaccine Hesitancy Scale (VHS). This scale has the potential to aid in the advancement of research and immunizatio...

A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity.

Our aim was to assess whether a novel approach of digitally facilitated, citizen-science research, as followed by the Swiss Multiple Sclerosis Registry (Swiss MS Registry), leads to accelerated partic...

Status of vaccine research and development for Helicobacter pylori.

Gastric adenocarcinoma is globally the third leading cause of death due to malignancy, with the bulk of this disease burden being suffered by low and middle income countries (LMIC), especially in Asia...

Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel Clinics.

Patients increasingly benefit from immunosuppressive/immunomodulatory medications for a range of conditions allowing them a lifestyle similar to healthy individuals, including travel. However, the adm...

Clinical Trials [4982 Associated Clinical Trials listed on BioPortfolio]

Rotavirus Vaccine Produced by Butantan Institute

The purpose of this study is to describe the safety, tolerability and immunogenicity of the pentavelent roatavirus vaccine produced by Butantan Institute.

Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea

The National Health Plan 2001-2010 calls for investigation of the feasibility of pneumococcal vaccines for Papau New Guinea. The Papua New Guinea (PNG) Institute of Medical Research, the T...

The Effects of the Swiss Ball on Cerebral Vascular Accident

The objective of this study was to investigate the effects of the Swiss ball on patients with hemiplegia due to CVA.

Swiss Army Physical Fitness Training

The purpose of this study is to determine whether the new sport concept of the Swiss Armed Forces influences the physical and psychological fitness of the recruits.

Swiss Trauma Registry

The Swiss Conference of Cantonal Health Directors has transferred the planning of highly specialized medicine to a specialized body under the direction of the Swiss Academy of Sciences. Th...

Companies [2604 Associated Companies listed on BioPortfolio]

Swiss Vaccine Research Institute

The SVRI is a partnership of five research institutes in Switzerland. The SVRI was created in 2007 in Lausanne and is supported by the Swiss Secretariat of Education and Research....

Swiss Institute for Experimental Cancer Research

1924 Creation of the "Centre Anticancéreux Romand (CACR)" in Lausanne. This Centre was involved both in research and in treatment. 1957 The CACR became devoted exclusively to scientific research. The...

Sabin Vaccine Institute

Sabin Vaccine Institute is a 501(c)(3) non-profit organization dedicated to reducing human suffering from infectious and neglected diseases. Through its efforts in vaccine research, development and ad...

Geneva Bioinformatics (GeneBio) S.A.

provides state of the art proteomics databases and software tools including the Swiss Institute of Bioinformatics' SWISS PROT, PROSITE, and SWISS 2DPAGE databases.

The Wistar Institute and Christiana Care Health System

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent ...

More Information about "Swiss Vaccine Research Institute" on BioPortfolio

We have published hundreds of Swiss Vaccine Research Institute news stories on BioPortfolio along with dozens of Swiss Vaccine Research Institute Clinical Trials and PubMed Articles about Swiss Vaccine Research Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Swiss Vaccine Research Institute Companies in our database. You can also find out about relevant Swiss Vaccine Research Institute Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record